| Company Name: |
Sigma-Aldrich |
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Company Name: |
Wuxi AppTec |
| Tel: |
022-59987777 13552403979 |
| Email: |
jia_guoqiang@wuxiapptec.com |
|
| | JP 92, NSC 43036, S-(+)-α-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride Basic information |
| Product Name: | JP 92, NSC 43036, S-(+)-α-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride | | Synonyms: | JP 92, NSC 43036, S-(+)-α-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride;JP 92;NSC 43036;(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE HYDROCHLORIDE;(S)-1-(3-(trifluoromethyl)phenyl)propan-2-amine hydrochloride;JP 92, NSC 43036, S-(+)-alpha-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride;S-(+)-alpha-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride;(S)-1-(3-(trifluoromethyl)phenyl)propan-2-amine HCl | | CAS: | 37936-89-3 | | MF: | C10H12F3N.ClH | | MW: | 239.667 | | EINECS: | | | Product Categories: | | | Mol File: | 37936-89-3.mol |  |
| | JP 92, NSC 43036, S-(+)-α-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride Chemical Properties |
| storage temp. | 2-8°C | | solubility | H2O: >10mg/mL | | form | powder | | color | white | | Water Solubility | H2O: >10mg/mL | | InChI | 1S/C10H12F3N.ClH/c1-7(14)5-8-3-2-4-9(6-8)10(11,12)13;/h2-4,6-7H,5,14H2,1H3;1H/t7-;/m0./s1 | | InChIKey | PIDLOFBRTWNFAR-FJXQXJEOSA-N | | SMILES | Cl.C[C@H](N)Cc1cccc(c1)C(F)(F)F |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36/37 | | WGK Germany | 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 |
| | JP 92, NSC 43036, S-(+)-α-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride Usage And Synthesis |
| Uses | (S)-Norfenfluramine Hydrochloride is a metabolite of (S)-(+)-Fenfluramine Hydrochloride (F247596); an anorexic. | | Biochem/physiol Actions | (+)-Norfenfluramine is the major hepatic metabolite of (+)-fenfluramine and is primarily responsible for the anorexic effect, as well as side effects; (+)-norfenfluramine causes vasoconstriction and a blood pressure increase in rats with normal blood; acts primarily on the cytoplasmic pool of serotonin; more potent than fenfluramine at inducing dopamine release. | | in vivo | (+)-Norfenfluramine (1-300 μg/kg, i.v.) hydrochloride induces pressor response in conscious SHAM and DOCA-salt rats[1].
(+)-Norfenfluramine (2.5 and 5 mg/kg, i.p.) hydrochloride decreases of 5-HT and 5-HIAA levels in telencephalon and brainstem of rats[3].
| Animal Model: | Conscious SHAM and DOCA-salt rats[1].
| | Dosage: | 1-300 μg/kg | | Administration: | Intravenous injection (i.v.), given in a cumulative fashion at 6-min intervals. | | Result: | Induced pressor response in conscious SHAM and DOCA-salt rats. (change in mean arterial blood pressure at 300 μg/kg, mm Hg, SHAM vehicle=36, SHAM ketanserin=7, DOCA=51, DOCA ketanserin=19). |
| | IC 50 | 5-HT2B Receptor: 11.2 nM (Ki); 5-HT2C Receptor: 324 nM (Ki); 5-HT2A Receptor: 1516 nM (Ki) |
| | JP 92, NSC 43036, S-(+)-α-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride Preparation Products And Raw materials |
|